Загрузка...
Novel antibody–drug conjugates for triple negative breast cancer
Triple negative breast cancer (TNBC) is a heterogenous subtype of breast cancer often associated with an aggressive phenotype and poor prognosis. Antibody–drug conjugate (ADC), comprising of a monoclonal antibody linked to a cytotoxic payload by a linker, is gaining increasing traction as an anti-ca...
Сохранить в:
| Опубликовано в: : | Ther Adv Med Oncol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2020
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7222243/ https://ncbi.nlm.nih.gov/pubmed/32426047 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835920915980 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|